BAKER BROS. ADVISORS LP – Kymera Therapeutics, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$62.69M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
+10.56%
quarter
Kymera Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 5.99M | $21.77 | 2.87M | |
| Q2 2022 | share | Increase | +20.76% | 495.08K shares | -44.21M | $19.69 | 2.87M |
| Q1 2022 | share | 0.00% | 0 shares | -50.48M | $42.32 | 2.38M | |
| Q4 2021 | share | 0.00% | 0 shares | 11.32M | $62.98 | 2.38M | |
| Q3 2021 | share | Increase | +21.72% | 425.53K shares | 45.05M | $58.74 | 2.38M |
| Q2 2021 | share | 0.00% | 0 shares | 18.88M | $48.5 | 1.95M | |
| Q1 2021 | share | 0.00% | 0 shares | -45.33M | $38.86 | 1.95M | |
| Q4 2020 | share | 0.00% | 0 shares | 58.16M | $62 | 1.95M | |
| Q3 2020 | share | Increase | 0.00% | 1.95M shares | 63.30M | $32.31 | 1.95M |